Therapeutic Asset Ratings
603 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
64Cu-Tz-SarAr
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
89zr-dfo-psmai-peg-cy5.5-c' dots
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Adclec.Syn1 Car T Cells
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Anti-Egfr-Bispecific Antibody Armed Activated T-Cells
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Autogene Cevumeran
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
azd1390
Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
crd3874
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Cytokine Induced Memory-Like Natural Killer Cells
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Egfrt/Bcma-41Bbz Car T Cell
Plasma Cell Myeloma
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Eli-002 7P
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
hu5B1-TCO
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
il-12
Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Mcarh109
Plasma Cell Myeloma
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Mcarh125
Plasma Cell Myeloma
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Mesothelin-Targeted T Cells
Breast Cancer
Memorial Sloan Kettering Cancer Center
P1
C
(36)
mq719
Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Msk-Tcr5
Cancer
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Msk-Tcr5
Neoplasm
Memorial Sloan Kettering Cancer Center
P1
C
(36)
-Nota-Psmai-Peg-Cy5.5-C' Dot Tracer
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Recombinant Human Interleukin-2
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
C
(36)
Romosozumab
Plasma Cell Myeloma
Memorial Sloan Kettering Cancer Center
P1
C
(36)
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2-(((4-(((3-((2R,5S,8S,14R)-5-(3-((AMINOIMINOMETHYL)AMINO)PROPYL)-14-((4-HYDROXYPHENYL)METHYL)-1-METHYL-8-(2-NAPHTHALENYLMETHYL)-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOPENTADEC-2-YL)PROPYL)AMINO)CARBONYL)PHENYL)METHYL)AMINO)-2-OXOETHYL)-
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Early P1
C
(36)
Pu-H71
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Early P1
C
(36)
Benralizumab
Breast Cancer
Memorial Sloan Kettering Cancer Center
P2
C
(33)
DIHYDROTESTOSTERONE
Breast Cancer
Memorial Sloan Kettering Cancer Center
Early P1
C
(33)
Showing 551 to 575 of 603 assets
Previous
Page 23 of 25
Next
